Stopped early
The Using Postoperative Ketamine and Exploring the Effect on Endometriosis Pain (UPKEEEP) Study
NCT05229653 · NYU Langone Health · Updated 28 March 2025
- What is being tested
- Ketamine; Placebo
- For
- Endometriosis; Post Operative Pain
- Kind of study
- Tests a treatment or device on volunteers. Phase 1.
- Who can join
- Ages 18 years to 65 years. About 1 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 12 April 2022, ends 21 Oct 2022. Registered 8 Feb 2022.
- Results
- Posted on the registry on 28 March 2025.
In the researchers' words
This is a randomized, single blinded, placebo-controlled trial to study the effectiveness of a subanesthetic dose (0.6 mg/kg) of ketamine versus placebo (saline) on postoperative pain and pain on adult female chronic pelvic pain patients undergoing robotic removal of endometriosis. The objective of the study is to explore the effect of a sub anesthetic dose of ketamine (0.6 mg/kg) vs. saline control on postoperative pain and recovery in chronic pelvic pain patients who have undergone robotic removal of endometriosis.
Sites
- NYU Langone HealthNew York, New York, United States